购物车
- 全部删除
您的购物车当前为空
Anti-DLL4 Antibody (9U391)
还可以产品编号 TMAY-00399
Anti-DLL4 Antibody (9U391) 是一种 Mouse 抗体，靶向 DLL4。Anti-DLL4 Antibody (9U391) 可用于 ELISA。
Anti-DLL4 Antibody (9U391)
Anti-DLL4 Antibody (9U391)
还可以产品编号 TMAY-00399
Anti-DLL4 Antibody (9U391) 是一种 Mouse 抗体，靶向 DLL4。Anti-DLL4 Antibody (9U391) 可用于 ELISA。
产品信息正在更新中，如果您想购买，请点击大包装&定制按钮.
大包装 & 定制
联系我们获取更多批次信息
资源下载
产品介绍
生物活性
偶联与修饰
抗原信息
| 产品描述 | Anti-DLL4 Antibody (9U391) is a Mouse antibody targeting DLL4. Anti-DLL4 Antibody (9U391) can be used in ELISA. |
| Ig Type | Monoclonal Mouse IgG2a |
| 克隆号 | 9U391 |
| 交叉反应 | Human |
| 应用 | ELISA |
| 推荐剂量 | ELISA: 1:1000-1:2000 |
| 抗体种类 | Monoclonal |
| 宿主来源 | Mouse |
| 构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human DLL4 / Delta-like 4 (rh DLL4; TMPY-01321; NP_061947.1; Met1-Pro524). |
| 纯化方式 | Protein A |
| 性状 | Liquid |
| 缓冲液 | 0.2 μm filtered solution in PBS |
| 研究背景 | Delta-like protein 4 (DLL4, Delta4), a type I membrane-bound Notch ligand, is one of five known Notch ligands in mammals and interacts predominantly with Notch 1, which has a key role in vascular development. Recent studies yield substantial insights into the role of DLL4 in angiogenesis. DLL4 is induced by vascular endothelial growth factor (VEGF) and acts downstream of VEGF as a 'brake' on VEGF-induced vessel growth, forming an autoregulatory negative feedback loop inactivating VEGF. DLL4 is downstream of VEGF signaling and its activation triggers a negative feedback that restrains the effects of VEGF. Attenuation of DLL4/Notch signaling results in chaotic vascular network with excessive branching and sprouting. DLL4 is widely distributed in tissues other than vessels including many malignancies. Furthermore, the molecule is internalized on binding its receptor and often transported to the nucleus. In pathological conditions, such as cancer, DLL4 is up-regulated strongly in the tumour vasculature. Blockade of DLL4-mediated Notch signaling strikingly increases nonproductive angiogenesis, but significantly inhibits tumor growth in preclinical mouse models. In preclinical studies, blocking of DLL4/Notch signaling is associated with a paradoxical increase in tumor vessel density, yet causes marked growth inhibition due to functionally defective vasculature. Thus, DLL4 blockade holds promise as an additional strategy for angiogenesis-based cancer therapy. |
| 偶联 | Unconjugated |
| 免疫原 | Recombinant Human DLL4 / Delta-like 4 protein (TMPY-01321) |
| 抗原种属 | Human |
| 研究领域 | Cancer Drug Targets, Notch Pathway |
存储&运输
| 储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| 运输方式 | Shipping with blue ice. |
SCI 文献
计算器
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
评论列表
预览
Related Tags: buy Anti-DLL4 Antibody (9U391) | purchase Anti-DLL4 Antibody (9U391) | Anti-DLL4 Antibody (9U391) cost | order Anti-DLL4 Antibody (9U391)
嗨！有任何问题？点我咨询
评论内容